Trial Profile

Pivotal study of VMX-C001

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 16 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Recombinant coagulation factor X VarmX (Primary)
Indications Haemorrhage
Focus Therapeutic Use

Most Recent Events

12 Oct 2023 According to a VarmX media release, Dr. Jeffrey Lawson will focus on completing all preparations for this pivotal trial.
01 Jun 2023 New trial record
25 May 2023 According to a VarmX media release, the company raised 30 Million Euro Series B2 financing for IND approval and preparations for this trial.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com